July 28, 2022 01:14 PM EDT
Manufacturing

Man­u­fac­tur­ing roundup: Gen­Bio­Pro looks to counter Mis­sis­sip­pi trig­ger law; Pis­gah Labs to in­vest $55M in NC ex­pan­sion  

Tyler Patchen

News Reporter

As the is­sues from the Roe V. Wade de­ci­sion con­tin­ue to cas­cade in var­i­ous cir­cles, in­clud­ing the biotech world, one man­u­fac­tur­er is look­ing to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times